featured
Plasma 25-Hydroxyvitamin D3 and Bladder Cancer Risk According to Tumor Stage and FGFR3 Status: A Mechanism-Based Epidemiological Study
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the National Cancer Institute
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Plasma 25-Hydroxyvitamin D3 and Bladder Cancer Risk According to Tumor Stage and FGFR3 Status: A Mechanism-Based Epidemiological Study
J. Natl. Cancer Inst 2012 Oct 29;[EPub Ahead of Print], AF Amaral, M Méndez-Pertuz, A Muñoz, DT Silverman, Y Allory, M Kogevinas, J Lloreta, N Rothman, A Carrato, Del Rivas, FX Real, N MalatsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.